1. Home
  2. RLAY vs VRTS Comparison

RLAY vs VRTS Comparison

Compare RLAY & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.66

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

HOLD

Current Price

$164.81

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
VRTS
Founded
2015
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2020
1992

Fundamental Metrics

Financial Performance
Metric
RLAY
VRTS
Price
$8.66
$164.81
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$16.00
$179.60
AVG Volume (30 Days)
2.3M
80.5K
Earning Date
11-06-2025
01-30-2026
Dividend Yield
N/A
5.94%
EPS Growth
N/A
18.44
EPS
N/A
19.47
Revenue
$8,355,000.00
$878,336,000.00
Revenue This Year
$20.47
N/A
Revenue Next Year
N/A
$0.15
P/E Ratio
N/A
$8.30
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$142.18
52 Week High
$9.04
$227.38

Technical Indicators

Market Signals
Indicator
RLAY
VRTS
Relative Strength Index (RSI) 66.58 52.37
Support Level $7.95 $160.39
Resistance Level $9.04 $168.25
Average True Range (ATR) 0.50 4.88
MACD 0.04 0.59
Stochastic Oscillator 77.78 61.63

Price Performance

Historical Comparison
RLAY
VRTS

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

Share on Social Networks: